KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Boston Scientific (BSX) Net Margin (2016 - 2026)

Boston Scientific's Net Margin history spans 18 years, with the latest figure at 25.77% for Q1 2026.

  • On a quarterly basis, Net Margin rose 1132.0% to 25.77% in Q1 2026 year-over-year; TTM through Mar 2026 was 17.29%, a 572.0% increase, with the full-year FY2025 number at 14.44%, up 337.0% from a year prior.
  • Net Margin hit 25.77% in Q1 2026 for Boston Scientific, up from 12.71% in the prior quarter.
  • Over the last five years, Net Margin for BSX hit a ceiling of 25.77% in Q1 2026 and a floor of 3.21% in Q1 2022.
  • Historically, Net Margin has averaged 11.29% across 5 years, with a median of 12.39% in 2024.
  • Biggest five-year swings in Net Margin: crashed -868bps in 2022 and later soared 1132bps in 2026.
  • Tracing BSX's Net Margin over 5 years: stood at 3.89% in 2022, then surged by 249bps to 13.56% in 2023, then decreased by -9bps to 12.39% in 2024, then increased by 3bps to 12.71% in 2025, then skyrocketed by 103bps to 25.77% in 2026.
  • Business Quant data shows Net Margin for BSX at 25.77% in Q1 2026, 12.71% in Q4 2025, and 14.91% in Q3 2025.